Chip Natrin, AstraZeneca is a significant property owner and developer in the Dallas-Fort Worth area with a comprehensive real estate portfolio of 1 construction projects valued at $2.1M. The development portfolio includes both new construction and renovations, with 0 new construction projects and 1 renovation projects representing 5,915 square feet of developed space.
With 1 active projects currently under development and 0 completed projects, Chip Natrin, AstraZeneca maintains a strong presence across 1 cities, working with leading architecture and design firms including The Beck Group. The development portfolio is concentrated in Coppell, establishing Chip Natrin, AstraZeneca as a key player in Dallas-Fort Worth commercial and residential real estate development.
1 architecture firms
